142
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Association of IL-17 and IL-23 Gene Variants with Plasma Levels and Risk of Vulvovaginal Candidiasis in a Chinese Han Population

, , , &
Pages 725-733 | Published online: 15 Dec 2020

References

  • Rodriguez-Cerdeira C, Gregorio MC, Molares-Vila A, et al. Biofilms and vulvovaginal candidiasis. Colloids Surf B Biointerfaces. 2019;174:110–125. doi:10.1016/j.colsurfb.2018.11.01130447520
  • Willems HME, Ahmed SS, Liu J, Xu Z, Peters BM. Vulvovaginal candidiasis: a current understanding and burning questions. J Fungi (Basel). 2020;6(1). doi:10.3390/jof6010027
  • Rosati D, Bruno M, Jaeger M, Ten OJ, Netea MG. Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms. 2020;8(2):144. doi:10.3390/microorganisms8020144
  • Yano J, Peters BM, Noverr MC, Fidel PL Jr. Novel mechanism behind the immunopathogenesis of vulvovaginal candidiasis: “Neutrophil anergy”. Infect Immun. 2018;86(3). doi:10.1128/IAI.00684-17
  • Goncalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905–927. doi:10.3109/1040841X.2015.109180526690853
  • Jaeger M, Pinelli M, Borghi M, et al. A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Sci Transl Med. 2019;11(496):496. doi:10.1126/scitranslmed.aar3558
  • Kalia N, Singh J, Sharma S, Kaur M. SNPs in 3ʹ-UTR region of MBL2 increases susceptibility to recurrent vulvovaginal infections by altering sMBL levels. Immunobiology. 2019;224(1):42–49. doi:10.1016/j.imbio.2018.10.00930482481
  • De Bernardis F, Graziani S, Tirelli F, Antonopoulou S. Candida vaginitis: virulence, host response and vaccine prospects. Med Mycol. 2018;56(suppl_1):26–31. doi:10.1093/mmy/myx13929538739
  • Hofs S, Mogavero S, Hube B. Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota. J Microbiol. 2016;54(3):149–169. doi:10.1007/s12275-016-5514-026920876
  • Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6(11):1123–1132. doi:10.1038/ni125416200070
  • Peters BM, Coleman BM, Willems HME, et al. The interleukin (IL) 17R/IL-22R signaling axis is dispensable for vulvovaginal candidiasis regardless of estrogen status. J Infect Dis. 2020;221(9):1554–1563. doi:10.1093/infdis/jiz64931805183
  • Pietrella D, Rachini A, Pines M, et al. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS One. 2011;6(7):e22770. doi:10.1371/journal.pone.002277021818387
  • Chen Y, Wood KJ. Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection? Transplantation. 2007;84(9):1071–1074. doi:10.1097/01.tp.0000287126.12083.4817998858
  • Bunte K, Beikler T. Th17 cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases. Int J Mol Sci. 2019;20(14):3394. doi:10.3390/ijms20143394
  • Liu J, Wang HZ, Sun Y. Inhibition of CXCR4 by MicroRNA-1192 reduces the activation of Th17 cells and expression of inflammation factors in a mouse model of vulvovaginal candidiasis. Cell Physiol Biochem. 2018;50(3):893–910. doi:10.1159/00049447530355939
  • Wang L, Wang C, Mei H, et al. Combination of estrogen and immunosuppressive agents to establish a mouse model of candidiasis with concurrent oral and vaginal mucosal infection. Mycopathologia. 2016;181(1–2):29–39. doi:10.1007/s11046-015-9947-526404163
  • Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006;116(5):1310–1316. doi:10.1172/JCI2140416670770
  • Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J Allergy Clin Immunol. 2007;120(2):247–254. doi:10.1016/j.jaci.2007.06.03917666214
  • Arisawa T, Tahara T, Shibata T, et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28(1):44–49. doi:10.1007/s10875-007-9125-817828618
  • Hammad A, Mosaad YM, Hammad EM, et al. Interleukin-17A rs2275913, interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis. Autoimmunity. 2016;49(1):31–40. doi:10.3109/08916934.2015.110107126515887
  • McGovern DP, Rotter JI, Mei L, et al. Genetic epistasis of IL23/IL17 pathway genes in Crohn’s disease. Inflamm Bowel Dis. 2009;15(6):883–889. doi:10.1002/ibd.2085519235914
  • Omrane I, Baroudi O, Bougatef K, et al. Significant association between IL23R and IL17F polymorphisms and clinical features of colorectal cancer. Immunol Lett. 2014;158(1–2):189–194. doi:10.1016/j.imlet.2014.01.00224440568
  • Tian J, Liu Y, Jiang Y, et al. Association of single nucleotide polymorphisms of IL23R and IL17 with necrotizing enterocolitis in premature infants. Mol Cell Biochem. 2017;430(1–2):201–209. doi:10.1007/s11010-017-2972-628224332
  • Louahchi S, Allam I, Berkani L, et al. Association study of single nucleotide polymorphisms of IL23R and IL17 in rheumatoid arthritis in the Algerian population. Acta Reumatol Port. 2016;41(2):151–157.27606475
  • Catanoso MG, Boiardi L, Macchioni P, et al. IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population. Rheumatol Int. 2013;33(5):1165–1176. doi:10.1007/s00296-012-2501-622955875
  • Aytekin N, Akcali C, Pehlivan S, Kirtak N, Inaloz S. Investigation of interleukin-12, interleukin-17 and interleukin-23 receptor gene polymorphisms in alopecia areata. J Int Med Res. 2015;43(4):526–534. doi:10.1177/030006051454978426017027
  • Yan W, Zhijian T, Zhixiang L, Dechao X, Jiawen J. Local IL-23 expression in murine vaginal candidiasis and its relationship with infection and immune status. J Huazhong Univ Sci Technol Med Sci. 2006;26(2):245–247. doi:10.1007/BF02895828
  • Kolben T, Pieper K, Goess C, et al. IL-23, IFN-alpha, and IFN-beta in the vaginal fluid of patients suffering from vulvovaginal candidosis. Clin Exp Obstet Gynecol. 2017;44(1):7–10.29714856